# US 2024/0002930 A1 · Enzymatic ligation of nucleic acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002930 A1
- Document ID: US20240002930A1
- Status: Published application
- Kind: A1
- Application number: 18/303,828
- Filed: 2023-04-20
- Published: 2024-01-04
- Earliest claimed: 2011-01-17
- Assignees: Life Technologies Corporation
- Applicants: Life Technologies Corporation
- Inventors: Stephen HENDRICKS; David J. KING
- Web page: https://patentgrep.com/patent/US20240002930A1

## CPC

- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- A61J 1/062: {Carpules}
- A61J 1/14: Details; Accessories therefor (A61J7/00 takes precedence; openers B65D, B67B7/00)
- B65B 3/003: {Filling medical containers such as ampoules, vials, syringes or the like}
- B65B 3/006: {Related operations, e.g. scoring ampoules}
- B65B 31/046: {the nozzles co-operating, or being combined, with a device for opening or closing the container or wrapper (B65B31/06 takes precedence)}
- B65D 15/02: {of curved, or partially curved, cross-section, e.g. cans, drums}
- C12N 9/93: {Ligases (6)}
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- A61J 2200/76: for fluid level
- A61J 2205/30: Printed labels
- A61M 5/008: {Racks for supporting syringes or needles}
- A61M 5/5086: {for indicating if defective, used, tampered with or unsterile}
- B65B 55/08: by irradiation
- B65B 55/10: by liquids or gases
- C12Q 2600/16: Primer sets for multiplex assays
- C12Y 605/01001: DNA ligase (ATP) (6.5.1.1)
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- B65B: MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING (bundling and pressing devices for cigars A24C1/44; devices for tensioning and securing binders adapted to be supported by the article or articles to be bound B25B25/00; applying closure members to bottles, jars or similar containers B67B1/00-B67B6/00; concurrent cleaning, filling and closing of bottles B67C7/00; emptying bottles, jars, cans, casks, barrels or similar containers B67C9/00)
- B65D: CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- C12Y: ENZYMES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Methods, assays, compositions and kits for the ligation of short polynucleotides are presented herein. The short polynucleotides are optionally no more than 7 nucleotides in length, and can be as short as 3 or 4 nucleotides in length. The ligation is optionally performed by CV ligase.

## Claims

### Claim at position 1

1-53. (canceled)

### Claim 54

An artificial small footprint ligase derived from a Hin (Haemophilus Influenzae) DNA ligase or any fragment or variant thereof that comprises the sequence of SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, and/or has one or more C-terminal amino acids deleted.

### Claim 55

An artificial small footprint ligase derived from a Hin DNA ligase or any fragment or variant thereof that consists of the sequence of SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8.

### Claim 56

An artificial small footprint ligase derived from a Hin DNA ligase that has at least 70% identity to SEQ ID NO: 5, said ligase comprising an amino acid mutation at position 193 of SEQ ID NO: 5, optionally wherein said amino acid mutation consists of changing the glycine at position 193 to aspartic acid or glutamic acid.

### Claim 57 (depends on 56)

The ligase of claim 56, wherein the ligase has at least 80% identity to SEQ ID NO: 5.

### Claim 58 (depends on 56)

The ligase of claim 56, wherein the ligase has at least 90% identity to SEQ ID NO: 5.

### Claim 59 (depends on 56)

The ligase of claim 56, wherein the ligase has at least 95% identity to SEQ ID NO: 5.

### Claim 60 (depends on 56)

The ligase of claim 56, wherein the ligase has at least 99% identity to SEQ ID NO: 5.

### Claim 61 (depends on 54)

The ligase of claim 54, wherein the ligase is isolated, purified or recombinant.

### Claim 62 (depends on 54)

A nucleic acid molecule encoding the ligase of claim 54.

### Claim 63 (depends on 62)

The nucleic acid of claim 62, wherein the nucleic acid is isolated, purified or recombinant.

### Claim 64 (depends on 62)

A vector comprising the nucleic acid molecule of claim 62.

### Claim 65 (depends on 64)

The vector of claim 64, wherein the vector is isolated, purified or recombinant.

### Claim 66 (depends on 64)

A host cell comprising the vector of claim 64.

### Claim 67 (depends on 66)

The host cell of claim 66, wherein the host cell is isolated, purified or recombinant.

### Claim 68 (depends on 66, 67)

A method of making a ligase comprising:
a. culturing the isolated recombinant host cell of claim 66 or 67 under conditions such that the ligase is expressed; and
b. recovering said ligase.

### Claim 69 (depends on 56)

The ligase of claim 56, wherein the amino acid mutation consists of changing the glycine at position 193 to aspartic acid.

### Claim 70 (depends on 56)

The ligase of claim 56, wherein the amino acid mutation consists of changing the glycine at position 193 to glutamic acid.

### Claim 71 (depends on 54)

The ligase of claim 54, wherein the ligase is attached to a solid support.

### Claim 72 (depends on 54)

The ligase of claim 54, wherein the ligase comprises a N-terminal nucleotidyltransferase (NTase) domain, the NTase domain including at least one motif selected from the group consisting of motif I, motif Ia, motif III, motif IIIa, motif IV, motif V, and motif VI.

### Claim 73 (depends on 54)

The ligase of claim 54, wherein the activity of the ligase comprises at least one of the following:
(1) provide a nucleophilic attack on ATP or NAD+ resulting in release of PPi or NMN and formation of a covalent ligase-adenylate intermediate;
(2) transfer adenylate to a 5′-end of a 5′-phosphate-terminated DNA strand to form DNA-adenylate; or
(3) form a covalent bond joining a polynucleotide termini and liberation of AMP.

### Claim 74 (depends on 54)

The ligase of claim 54, wherein the ligase can mediate at least one of the following bond transformations: phosphoanhydride to phosphoramidate, phosphoramidate to phosphoanhydride, or phosphoanhydride to phosphodiester.
